Literature DB >> 2298483

Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.

P J Fedorka-Cray1, M J Huether, D L Stine, G A Anderson.   

Abstract

We partially characterized a cell extract (CE) from Actinobacillus pleuropneumoniae serotype 1 and used the CE to test the efficacy of secreted proteins against disease. Secreted products from 4-h culture supernatants were precipitated with 20% polyethylene glycol. Analysis of the CE indicated the presence of protein, endotoxin, and carbohydrate. Hemolytic activity to bovine erythrocytes and cytotoxic activity to porcine mononuclear leukocytes was also demonstrated. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the CE from a 4-h culture showed a major band at 110 kilodaltons (kDa), while a CE of a 26-h culture indicated the presence of a number of additional proteins, including the 110-kDa protein. The 110-kDa protein was also identified as a glycoprotein by periodic acid-Schiff and silver staining. A single band precipitated against convalescent-phase pig antiserum when the polyethylene glycol precipitate was used in an Ouchterlony plate. Vaccination with CE conferred greater protection against challenge with the homologous serotype than either a commercial bacterin or an outer membrane protein vaccine. Hemolysin-neutralizing titers were higher both pre- and postchallenge in the group vaccinated with the CE compared with in all other groups. We believe that this demonstrates the importance of secreted factors in protection against disease and suggests that the 110-kDa protein is an important immunogen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298483      PMCID: PMC258463          DOI: 10.1128/iai.58.2.358-365.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Immunogenicity of Outer Membrane Components of Haemophilus (Actinobacillus) pleuropneumoniae.

Authors:  V J Rapp; R F Ross
Journal:  Can Vet J       Date:  1988-07       Impact factor: 1.008

2.  Serotyping of Haemophilus pleuropneumoniae in the Netherlands: with emphasis on heterogeneity within serotype 1 and (proposed) serotype 9.

Authors:  E M Kamp; J K Popma; L A Van Leengoed
Journal:  Vet Microbiol       Date:  1987-03       Impact factor: 3.293

3.  Outer membrane protein profiles of Haemophilus pleuropneumoniae.

Authors:  V J Rapp; R S Munson; R F Ross
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Preparation and characterisation of envelope proteins from Haemophilus pleuropneumoniae.

Authors:  A N Rycroft; D J Taylor
Journal:  Vet Microbiol       Date:  1987-12       Impact factor: 3.293

6.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.

Authors:  S Bhakdi; N Mackman; J M Nicaud; I B Holland
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

7.  Interaction between heat-stable hemolytic substance from Haemophilus pleuropneumoniae and porcine pulmonary macrophages in vitro.

Authors:  K Kume; T Nakai; A Sawata
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Vaccine potential of Haemophilus pleuropneumoniae oligosaccharide-tetanus toxoid conjugates.

Authors:  B W Fenwick; B I Osburn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

9.  Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae.

Authors:  R Higgins; S Larivière; K R Mittal; G P Martineau; P Rousseau; J Cameron
Journal:  Can Vet J       Date:  1985-02       Impact factor: 1.008

10.  Vaccination against pleuropneumonia of pigs caused by Haemophilus pleuropneumoniae.

Authors:  S Rosendal; D S Carpenter; W R Mitchell; M R Wilson
Journal:  Can Vet J       Date:  1981-02       Impact factor: 1.008

View more
  14 in total

1.  Association of the RTX proteins of Actinobacillus pleuropneumoniae with hemolytic, CAMP, and neutrophil-cytotoxic activities.

Authors:  J Devenish; J E Brown; S Rosendal
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon.

Authors:  C T Prideaux; C Lenghaus; J Krywult; A L Hodgson
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.

Authors:  W Byrd; S Kadis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae.

Authors:  J N Ma; T J Inzana
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

6.  Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae.

Authors:  J Devenish; S Rosendal; J T Bossé
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

7.  Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines.

Authors:  T J Inzana; J Todd; H P Veit
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

8.  Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines.

Authors:  P J Willson; A Rossi-Campos; A A Potter
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

9.  Immunogenicity of Actinobacillus pleuropneumoniae outer membrane proteins and enhancement of phagocytosis by antibodies to the proteins.

Authors:  R N Thwaits; S Kadis
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

10.  Actinobacillus pleuropneumoniae-induced thymic lesions in mice and pigs.

Authors:  D L Stine; M J Huether; R A Moxley; S Srikumaran
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.